Budesonide chemical structure
Find information on thousands of medical conditions and prescription drugs.

Budesonide

Budesonide is a corticosteroid for the treatment of asthma, non-infectious rhinitis (including hay fever and other allergies), and for treatment and prevention of nasal polyposis. Additionally, it is used for inflammatory bowel disease. It is marketed by AstraZeneca as a nasal inhalation with the brand name Rhinocort, as an oral inhalation with the brand name Pulmicort, and as an enema and a modified-release capsule with the brand name Entocort. It is also sold in combined with formoterol (Oxis) in a single inhaler, with the brand name Symbicort. more...

Home
Diseases
Medicines
A
B
Baciim
Bacitracin
Baclofen
Bactrim
Bactroban
Barbexaclone
Barbital
Baros
Basiliximab
Baycol
Beclamide
Beclometasone
Beclovent
Beconase
Beldin
Benadryl
Benazepril
Bendroflumethiazide
Benserazide
Bentiromide
Benylin
Benzaclin
Benzalkonium chloride
Benzocaine
Benzonatate
Betacarotene
Betadine
Betahistine
Betamethasone
Betaxolol
Bextra
Biaxin
Bibrocathol
Bicalutamide
Bicillin
Biclotymol
Biotin
Bisoprolol
Bleomycin
Blocadren
Boldenone
Boniva
Bontril
Bosentan
Bravelle
Brethaire
Brevibloc
Brevicon
Bricanyl
Bromazepam
Bromelain
Bromhexine
Bromocriptine
Brompheniramine
Bronkodyl
Bronopol
BSS
Bucet
Budesonide
Bumetanide
Bupivacaine
Buprenex
Buprenorphine
Buserelin
Buspar
Buspirone
Busulfan
Butalbital
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Budesonide has a high first pass metabolism. It has efficacy in the terminal ileum and the right colon. It has a lower incidence of systemic manifestations than similar medications.

Read more at Wikipedia.org


[List your site here Free!]


Prospective study comparing the efficacy of oral procaterol + low dose inhaled budesonide vs high dose inhaled budesonide alone in preventing exacerbations
From CHEST, 10/1/05 by Ronald Allan F. Austria

PURPOSE: The aim of this study was to determine if addition of oral procaterol to low dose budesonide was comparable to high dose budesonide in preventing exacerbations anaong moderate persistent asthmatics.

METHODS: A 16 week prospective study was conducted in 20 patients aged 7-18 years moderate persistent asthmatics. After a 2 week run-in period, patients were randomized to treatment with either oral procaterol 25ug/dose BID + low dose budesonide (400ug/day) or high dose budesonide (800ug/day) alone. Lung function was measured serially and patients kept a diary of symptoms and bronchodilator use.

RESULTS: Forced expiratory volume in 1 second (FEV1) at 6th week was significantly increased in both treatment groups (p-0.03), likewise in symptoms, nocturnal cough(p-0.02) and daytime cough(p-0.01).There was no significant difference between the treatment groups in all the parameters measured.

CONCLUSION: This study demonstrated improvement in pulmonary function and symptom control in both treatment groups. However, clinical efficacy between the two treatment groups showed no significant difference in preventing exacerbations among moderate persistent asthmatics, probably because of the relatively small sample size involved. Thus, the author recommends to increase sample size to achieve significant outcome.

CLINICAL IMPLICATIONS: This study wants to determine that adding oral procaterol to low dose budesonide was comparable to high dose budesonide in preventing exacerbations among moderate persistent asthmatics thereby, may be used as an alternative treatment regimen among moderate persistent asthmatics.

DISCLOSURE: Ronald Allan Austria, Grant monies (from sources other than industry) The Philippine Children's Medical Center research fund shouldered the payment of spirometry fee of all patients in this study.; Grant monies (from industry related sources) otsuka provided the procaterol used by patients in this study while Astra provided the budesonide used by patients in this study.

Ronald Allan F. Austria MD * Arnel Gerald Q. Jiao MD Ma. Cecillia C. Nierva MD Beatriz Praxedes Apo I. Mandanas MD Celia T. Tardaguila RRT Philippine Children's Medical Center, Quezon, Philippines

COPYRIGHT 2005 American College of Chest Physicians
COPYRIGHT 2005 Gale Group

Return to Budesonide
Home Contact Resources Exchange Links ebay